Adjuvant treatment in biliary tract cancer.
Journal Information
Journal Title: Transl Cancer Res
Detailed journal information not available.
Publication Details
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2018.08.17). The series “Primary Liver Cancer” was commissioned by the editorial office without any funding or sponsorship. GB served as the unpaid Guest Editor of the series and serves as the unpaid editorial board member of Translational Cancer Research from Jan 2019 to Dec 2020. The authors have no other conflicts of interest to declare."
Funding Disclosure
Evidence found in paper:
"Funding: None."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025